These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1323 related articles for article (PubMed ID: 26586116)

  • 1. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
    Yao H; Liu X; Chen S; Xia W; Chen X
    Int J Clin Exp Pathol; 2015; 8(11):14830-5. PubMed ID: 26823812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.
    Meng FL; Wang W; Jia WD
    Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
    Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
    Cao C; Wang C
    Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
    Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
    PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
    An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
    World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.